Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study (Q42853726)

8 November 2017

Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study (English)

1 reference

8 November 2017

1 reference

Elif Küpeli

1

1 reference

8 November 2017

Gaye Ulubay

2

1 reference

8 November 2017

Sevinc Sarinc Ulasli

3

1 reference

8 November 2017

Tugce Sahin

4

1 reference

8 November 2017

Zeynep Erayman

5

1 reference

8 November 2017

Alptekin Gürsoy

6

1 reference

8 November 2017

9 June 2010

1 reference

8 November 2017

1 reference

8 November 2017

38

1 reference

8 November 2017

1

1 reference

8 November 2017

76-82

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-010-9351-3

8 November 2017

0 references

cites work

Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9351-3

The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9351-3

C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9351-3

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-010-9351-3

Biomarkers of systemic inflammation in stable and exacerbation phases of COPD

21 January 2018

1 reference

12 December 2020

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

1 reference

12 December 2020

The metabolic syndrome

1 reference

12 December 2020

Systemic effects of chronic obstructive pulmonary disease

1 reference

12 December 2020

Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.

1 reference

12 December 2020

Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.

1 reference

12 December 2020

Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis

1 reference

12 December 2020

Systemic manifestations and comorbidities of COPD.

1 reference

12 December 2020

Airflow obstruction and metabolic syndrome: the Guangzhou Biobank Cohort Study.

1 reference

12 December 2020

Glucose homeostasis across human airway epithelial cell monolayers: role of diffusion, transport and metabolism

1 reference

12 December 2020

Physiological changes during symptom recovery from moderate exacerbations of COPD.

1 reference

12 December 2020

Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study

1 reference

12 December 2020

Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome

1 reference

12 December 2020

Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Immunologic effects of acute hyperglycemia in nondiabetic rats

1 reference

12 December 2020

The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD).

1 reference

12 December 2020

Systemic Cytokines, Clinical and Physiological Changes in Patients Hospitalized for Exacerbation of COPD

1 reference

12 December 2020

The metabolic syndrome in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

Body composition and functional limitation in COPD.

1 reference

12 December 2020

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

1 reference

12 December 2020

Inflammatory changes, recovery and recurrence at COPD exacerbation

1 reference

12 December 2020

Increased tumour necrosis factor‐α plasma levels during moderate-intensity exercise in COPD patients

1 reference

12 December 2020

Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study

1 reference

12 December 2020

Interpretative strategies for lung function tests

1 reference

12 December 2020

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

1 reference

12 December 2020

The metabolic syndrome and inflammation

1 reference

12 December 2020

Standardisation of spirometry

1 reference

12 December 2020

Standardisation of the measurement of lung volumes

1 reference

12 December 2020

Hyperglycemia and cystic fibrosis alter respiratory fluid glucose concentrations estimated by breath condensate analysis

1 reference

12 December 2020

COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care

1 reference

12 December 2020

Obesity and the lung: 5. Obesity and COPD.

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes.

1 reference

12 December 2020

Longitudinal follow-up of systemic inflammation after acute exacerbations of COPD

1 reference

12 December 2020

Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels

1 reference

12 December 2020

The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease

1 reference

12 December 2020

The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease

1 reference

12 December 2020

Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes.

1 reference

12 December 2020

Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men

1 reference

12 December 2020

Local and Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease

1 reference

12 December 2020

Comparison of clinical characteristics and outcomes of patients with COPD exacerbation with or without venous thromboembolism.

1 reference

12 December 2020

Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance

1 reference

12 December 2020

Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors

1 reference

12 December 2020

Changes in bronchial inflammation during acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care

1 reference

12 December 2020

10.1007/S12020-010-9351-3

Identifiers

DOI

1 reference

Dimensions Publication ID

8 November 2017

0 references

1 reference